Scientia Advisors - Science, knowledge and skill for your competitive advantage

LinkedIn Facebook Twitter Delicious

Due Diligence

Venture capital and private equity firms have vastly different approaches, deal targets and processes, when vetting prospective investment opportunities.  Scientia Advisors understands these discriminating mindsets and helps with the painstaking task of due diligence by bringing to the table life science industry expertise, technical, operational and entrepreneurial experience, independence and analytical rigor.

Scientia Advisors' APPROACH TO DUE DILIGENCE

As part of our due diligence process, we help clients with the following:

  • Concentrate on the key issues that will determine the investment’s ultimate success.
  • Assess with accuracy key industry performance issues, technology development minefields, relevant markets and customer benchmarks.
  • Develop an agenda for creating value once the deal is closed.
  • Evaluate exit options.

To learn more about Scientia Advisors' Capital Investment and Due Diligence consulting capabilities, please contact us.

Scientia Advisors Leaders »

Harry Glorikian »
Founder and Managing Partner

Arshad Ahmed »
Founding Partner

Patrick Terry »
Principal


Industry Reviews »

Opportunities in Vascular Devices: New Developments to Change the Treatment Paradigm and Drive Growth


ScientiaNET »

ScientiaNET is comprised of over 40,000 leading scientists, physicians, practitioners, and industry professionals who provide clients with access to subject matter expertise across the entire life science spectrum.

SCIENTIA ADVISORS, LLC  |  info@scientiaadv.com


55 Cambridge Parkway, Suite 300E, Cambridge MA 02142  |  Phone: 617-299-3000  |  Fax: 617-812-0315

© 2012 Scientia Advisors LLC